These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 23452390
1. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. Fedorova EV, Skochilov RV, Heimer R, Case P, Beletsky L, Grau LE, Kozlov AP, Shaboltas AV. BMC Public Health; 2013 Mar 01; 13():183. PubMed ID: 23452390 [Abstract] [Full Text] [Related]
2. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD. J Urban Health; 2010 Dec 01; 87(6):942-53. PubMed ID: 21116724 [Abstract] [Full Text] [Related]
3. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley. Pollini RA. J Am Pharm Assoc (2003); 2017 Dec 01; 57(6):677-685. PubMed ID: 28807658 [Abstract] [Full Text] [Related]
4. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon. Ghaddar A, Nassar K, Elsoury G. Subst Use Misuse; 2017 Sep 19; 52(11):1420-1428. PubMed ID: 28430013 [Abstract] [Full Text] [Related]
5. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. Coffin PO, Linas BP, Factor SH, Vlahov D. J Urban Health; 2000 Dec 19; 77(4):781-93. PubMed ID: 11194317 [Abstract] [Full Text] [Related]
6. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices. Wright-De Agüero L, Weinstein B, Jones TS, Miles J. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 19; 18 Suppl 1():S102-10. PubMed ID: 9663632 [Abstract] [Full Text] [Related]
8. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. Lewis BA, Koester SK, Bush TW. J Am Pharm Assoc (Wash); 2002 Dec 19; 42(6 Suppl 2):S46-51. PubMed ID: 12489615 [Abstract] [Full Text] [Related]
9. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. J Acquir Immune Defic Syndr; 2001 Jun 01; 27(2):183-92. PubMed ID: 11404541 [Abstract] [Full Text] [Related]
10. Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users. Crawford ND, Amesty S, Rivera AV, Harripersaud K, Turner A, Fuller CM. Health Educ Behav; 2014 Aug 01; 41(4):397-405. PubMed ID: 24722219 [Abstract] [Full Text] [Related]
11. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? Lurie P, Jones TS, Foley J. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug 01; 18 Suppl 1():S45-51. PubMed ID: 9663623 [Abstract] [Full Text] [Related]
12. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Public Health Rep; 1998 Jun 01; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813 [Abstract] [Full Text] [Related]
13. Over-the-counter but out of reach: a pharmacy-based survey of OTC syringe sales in Tijuana, Mexico. Pollini RA, Gallardo M, Ruiz S, Case P, Zaller N, Lozada R. J Health Care Poor Underserved; 2014 May 01; 25(2):637-51. PubMed ID: 24858873 [Abstract] [Full Text] [Related]
14. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018. Meyerson BE, Lawrence CA, Cope SD, Levin S, Thomas C, Eldridge LA, Coles HB, Vadiei N, Kennedy A. Harm Reduct J; 2019 Sep 18; 16(1):57. PubMed ID: 31533730 [Abstract] [Full Text] [Related]
15. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. Case P, Beckett GA, Jones TS. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep 18; 18 Suppl 1():S94-101. PubMed ID: 9663631 [Abstract] [Full Text] [Related]
16. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention. Zaller ND, Yokell MA, Apeakorang N, Gaggin J, Case P. J Health Care Poor Underserved; 2012 Aug 18; 23(3):1310-26. PubMed ID: 24212176 [Abstract] [Full Text] [Related]
17. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies. Rudolph AE, Crawford ND, Ompad DC, Benjamin EO, Stern RJ, Fuller CM. J Am Pharm Assoc (2003); 2012 Aug 18; 50(2):140-7. PubMed ID: 20199954 [Abstract] [Full Text] [Related]
18. Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study. Pollini RA, Lozada R, Gallardo M, Rosen P, Vera A, Macias A, Palinkas LA, Strathdee SA. AIDS Behav; 2010 Jun 18; 14(3):679-87. PubMed ID: 20300820 [Abstract] [Full Text] [Related]
19. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. Taussig JA, Weinstein B, Burris S, Jones TS. AIDS; 2000 Jun 18; 14 Suppl 1():S47-51. PubMed ID: 10981474 [Abstract] [Full Text] [Related]
20. Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings. Lutnick A, Case P, Kral AH. J Urban Health; 2012 Apr 18; 89(2):354-64. PubMed ID: 22231488 [Abstract] [Full Text] [Related] Page: [Next] [New Search]